Gynaecologic Cancer

6

Review clinical trials related to Gynaecologic Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Holistic Acupuncture for Patients With Chemotherapy Induced Nausea

The study explores whether acupuncture as a supplement to conventional antiemetic medicine is superior in reducing the level of chemotherapy induced nausea compared to conventional anitemetic medicine alone. A total of 90 patients experiencing chemotherapy induced nausea will be allocated 1:1 to either acupuncture and antiemetic medicine or antiemetic medicine alone. The level of nausea and other cancer related symptoms will be assessed at baseline and 8 and 22 days after enrollment

Participants needed: 90
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Vejle HospitalUpdated: May 28, 2026Locations: 1
Eligibility criteria

≥ 18 years of age [+5]

Brain metastases [+1]

Status: Not yet recruiting

Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic Cancer

This is a multicenter, national, interventional, cluster-randomized study, "stepped wedge" design. This study includes patients with metastatic or locally advanced digestive, gynecological, ENT, or sarcoma cancer, currently undergoing systemic palliative treatment and hospitalized on an unscheduled basis. The study will aim to evaluate the impact of early palliative care implementation for patients with metastatic or advanced cancer identified during an unplanned hospitalization.

Participants needed: 493
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Centre Oscar LambretUpdated: Mar 24, 2026Locations: 1
Eligibility criteria

Subjects aged 18 years and older; [+5]

PS (WHO) = 4; [+4]

Status: Not yet recruiting

GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries

The purpose of study is to compare the side effects of two different forms of radiation for endometrial and cervical cancer. If you decide to enroll in this study, you will be randomized to one of two treatment groups. This study will compare two standard of care treatments: "Conventional" pHoton radiation versus pRoton radiation.

Participants needed: 116
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of Maryland, BaltimoreUpdated: Feb 17, 2026Locations: 5
Eligibility criteria

a. Newly diagnosed endometrial cancer after TAH/BSO and nodal sampling, sentinel... [+5]

Metastatic disease beyond para-aortic lymph nodal region [+10]

Status: Not yet recruiting

More Representative Vaginal Temperature Measurements With a Hyperthermia Pelotte During Hyperthermia Treatments for Gynaecological Cancer.

The goal of this comparative, cross over single centre study is to to determine whether the average measured vaginal temperature during hyperthermia treatment is (clinically) significant different with the use of a pelotte than with a standard vaginal probe. in 27 women treated with external beam radiotherapy and deep hyperthermie for gynaecological cancer.. The primary endpoint is measured average vaginal temperatures with pelotte versus a standard vaginal probe. The secondary endpoints are: reproducibility of catheter placement, patient comfort, inter-fractional spread of the vaginal temperature and the average vaginal temperature at the tip (0 cm) and 2 cm from the tip with pelotte and a standard vaginal probe. Participants will be treated at least two time with a pelotte and two times with a standard vaginal probe. Participants will be asked to fill in a short questionnaire three times per treatment (before, during and after treatment). A total of 12-15 questionnaires will be completed by the participants over the four to five treatments.

Participants needed: 27
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Dr. G.H. (Henrike) WesterveldUpdated: Nov 19, 2025Locations: 1
Eligibility criteria

Women aged 18 or older diagnosed with gynaecological cancer [+2]

Any condition potentially interfering with the understanding of the study requir... [+1]

Status: Recruiting

Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study

ERAS (Enhanced Recovery After Surgery) protocols are step-by-step care plans that help patients recover faster after surgery. They focus on keeping the body's normal functions, lowering stress from surgery, and supporting a quicker recovery. In gynecologic cancer surgeries, ERAS has been shown to help patients do better, have fewer problems, and leave the hospital sooner. A prehabilitation program, in combination with ERAS protocols, aims to optimize patients' physical and psychological condition prior to surgery for gynecological cancers. Interventions may include tailored exercise, nutritional support, respiratory training, and psychological preparation. By enhancing baseline fitness and resilience, prehabilitation improves the body's ability to tolerate surgical stress, reduces complications, and facilitates a faster, smoother recovery within the ERAS framework.

Participants needed: 100
Trial details
Age: 18-85Biological sex: FemaleType: InterventionalSponsor: Aristotle University Of ThessalonikiUpdated: Oct 7, 2025Locations: 1
Eligibility criteria

Type of gynecological malignancy: endometrial cancer, ovarian cancer, cervical c... [+5]

Women with performance status: ECOG >2 and ASA score >III [+1]

Status: Not yet recruiting

Improving Sexual Health in Gynecological Cancer Patients

The goal of this clinical trial is to test whether a nurse-led program can improve screening and referral rates for sexual dysfunction and improve sexual health care in individuals with gynecological cancer. The main questions it aims to answer are: Does participation in a nurse-led program improve the treatment of sexual dysfunction in individuals with gynecological cancer? Does the program increase the frequency of screenings and referrals for sexual dysfunction? Participants will: Complete a visit with an advanced practice provider. Fill out the Female Sexual Function Index survey. Allow the research team to review medical records.

Participants needed: 35
Trial details
Age: 30-65Biological sex: FemaleType: InterventionalSponsor: Cedars-Sinai Medical CenterUpdated: Aug 27, 2025Locations: 1
Eligibility criteria

Patients with a gynecologic cancer history [+7]